Schizophrenia 6

Common Name(s)

Schizophrenia 6

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Schizophrenia 6" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Schizophrenia 6" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Schizophrenia 6" returned 24 free, full-text research articles on human participants. First 3 results:

Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study.
 

Author(s): Stephen M Stahl, Josephine Cucchiaro, Doreen Simonelli, Jay Hsu, Andrei Pikalov, Antony Loebel

Journal: J Clin Psychiatry. 2013 May;74(5):507-15.

 

The primary objective was to evaluate the safety and tolerability of lurasidone, a new atypical antipsychotic agent, in the longer-term treatment of schizophrenia (DSM-IV). Persistence of symptom improvement was assessed as a secondary outcome.

Last Updated: 14 Jun 2013

Go To URL
Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.
 

Author(s): Joseph P McEvoy, Leslie Citrome, David Hernandez, Josephine Cucchiaro, Jay Hsu, Andrei Pikalov, Antony Loebel

Journal: J Clin Psychiatry. 2013 Feb;74(2):170-9.

 

To examine the effectiveness of switching patients to lurasidone using 3 different dosing strategies.

Last Updated: 11 Mar 2013

Go To URL
Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia.
 

Author(s): Bojana Dunjic-Kostic, Miroslava Jasovic-Gasic, Maja Ivkovic, Nevena V Radonjic, Maja Pantovic, Aleksandar Damjanovic, Sanja Totic Poznanovic, Aleksandar Jovanovic, Tatjana Nikolic, Natasa D Petronijevic

Journal: Psychiatr Danub. 2013 Mar;25(1):55-61.

 

The variations in proinflamatory cytokine levels have been associated with schizophrenia (SCH), duration of illness, psychopathology and treatment. The aim of the study was to investigate serum levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in schizophrenic ...

Last Updated: 8 Mar 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Schizophrenia 6" returned 2 free, full-text review articles on human participants. First 3 results:

Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse.
 

Author(s): Matcheri S Keshavan, Henry A Nasrallah, Rajiv Tandon

Journal: Schizophr. Res.. 2011 Apr;127(1-3):3-13.

 

The current construct of schizophrenia as a unitary disease is far from satisfactory, and is in need of reconceptualization. The first five papers in our "facts" series reviewed what is known about schizophrenia to date, and a limited number of key facts appear to stand out. Schizophrenia ...

Last Updated: 8 Mar 2011

Go To URL
Schizophrenia and alterations in self-experience: a comparison of 6 perspectives.
 

Author(s): Paul H Lysaker, John T Lysaker

Journal: Schizophr Bull. 2010 Mar;36(2):331-40.

 

Contemporary researchers have tended to examine dysfunction among the lives of persons with schizophrenia as a matter of the impact of biological and social forces. While this has greatly advanced the knowledge base, any account of schizophrenia without a full consideration of the ...

Last Updated: 8 Mar 2010

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Pediatric Schizophrenia Efficacy and Safety Study
 

Status: Recruiting

Condition Summary: Schizophrenia

 

Last Updated: 8 Sep 2014

Go to URL

Last Updated: 10 Sep 2013

Go to URL
Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia
 

Status: Recruiting

Condition Summary: Schizophrenia; Schizoaffective Disorder

 

Last Updated: 23 May 2014

Go to URL